CHRONIC LYMPHATIC LEUKEMIA

18 June 1949

journal article
research article
Published by American Medical Association (AMA) in JAMA

Vol. 140 (7) , 585-588
https://doi.org/10.1001/jama.1949.02900420005002

Abstract

In a previous article¹were reported 129 cases of chronic myelogenous leukemia treated primarily with radioactive phosphorus (P³²). In the present paper a similar study of lymphatic leukemia is presented, based on our total experience in the use of P³²since we started these investigations. Included in the series of 100 cases are all patients with this condition who have been treated with radioactive phosphorus at the University of California in Berkeley and San Francisco since the work was started by one of us in 1936 until March 1, 1947, and followed until Sept. 1, 1948. PREPARATION OF RADIOPHOSPHORUS P³²in the form of isotonic sodium mono-hydrogen phosphate was prepared according to methods previously described.²The former source of the P³²was the P³¹(n,p) P³²reaction in the cyclotron, but more recently the high yield of the S³²(n,p)P³²

Keywords

This publication has 1 reference indexed in Scilit:

THE THERAPEUTIC USE OF RADIOACTIVE PHOSPHORUS
The Lancet Healthy Longevity, 1945